advertisement
Editors Selection IGR 19-3
List of Editor's Selection comments by
Makoto Aihara
Department of Ophthalmology, University of Tokyo, Japan
Medical Treatment: Gene Therapy (23-4, October 2023) on:
108419 Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma
O'Callaghan J; Delaney C; O'Connor M et al. et al.
Science advances 2023; 9: eadf6537
Basic science: Neuroprotection through mitochondrial transport restoration (23-3, July 2023) on:
105770 Restoration of mitochondria axonal transport by adaptor Disc1 supplementation prevents neurodegeneration and rescues visual function
Quintero H; Shiga Y; Belforte N et al.
Cell reports 2022; 40: 111324
Basic science: Insights into the pharmacology of a selective EP2-R agonist (23-3, July 2023) on:
106832 Downregulation of COL12A1 and COL13A1 by a selective EP2 receptor agonist, omidenepag, in human trabecular meshwork cells
Kumon M; Fuwa M; Shimazaki A et al.
PLoS ONE 2023; 18: e0280331
Clinical Examination Methods: Long-term IOP variations in Normal-Tension Glaucoma (22-3, April 2022) on:
96140 Seasonal Variation and Trend of Intraocular Pressure Decrease Over a 20-Year Period in Normal-Tension Glaucoma Patients
Ikeda Y; Mori K; Ueno M et al.
American Journal of Ophthalmology 2021; 234: 235-240
Medical Treatment: Natrsudil combinations (22-1, October 2021) on:
92762 Effectiveness and Tolerability of Netarsudil in Combination with Other Ocular Hypotensive Agents
Prager AJ; Tang M; Pleet AL et al.
Ophthalmology. Glaucoma 2021; 4: 597-603
Models of Glaucoma: A new Murine Model of Glaucoma (19-4, March 2019) on:
78021 A murine glaucoma model induced by rapid in vivo photopolymerization of hyaluronic acid glycidyl methacrylate
Guo C; Qu X; Rangaswamy N et al.
PLoS ONE 2018; 13: e0196529
Basic Science: Oxidative Stress in the ONH (19-3, December 2018) on:
76536 Elevated intracellular cAMP exacerbates vulnerability to oxidative stress in optic nerve head astrocytes
Shim MS; Kim KY; Bu JH et al.
Cell Death and Disease 2018; 9: 285
Clinical examination methods: Outflow facility (17-4, September 2016) on:
67303 Measurement of Outflow Facility Using iPerfusion
Sherwood JM; Reina-Torres E; Bertrand JA et al.
PLoS ONE 2016; 11: e0150694
Basic Research: Aqueous humor dynamics (13-1, June 2011) on:
27733 Assessment of Aqueous Humor Dynamics in the Mouse by a Novel Method of Constant-Flow Infusion
Millar JC; Clark AF; Pang L-H
Investigative Ophthalmology and Visual Science 2011; 52: 685-694
Basic Research: ASK-1 deficiency in an NTG model (12-2, September 2010) on:
25929 ASK1 deficiency attenuates neural cell death in GLAST-deficient mice, a model of normal tension glaucoma
Harada C; Namekata K; Guo X et al.
Cell Death and Differentiation ;
Blood Flow: Prostaglandins and blood flow in rabbits (12-1, June 2010) on:
25421 Ocular hypotensive effects of anti-glaucoma agents in mice
Akaishi T; Odani-Kawabata N; Ishida N et al.
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 401-407
Basic Research: Protective role of GLT-1 (11-4, March 2010) on:
24530 Differential expression of two glutamate transporters, GLAST and GLT-1, in an experimental rat model of glaucoma
Park CK; Cha J; Park SC et al.
Experimental Brain Research 2009; 197: 101-109
Comments (11-3, December 2009) on:
24490 Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma
Lambiasea A; Aloe L; Centofanti M et al.
Proceedings of the National Academy of Sciences of the United States of America 2009; 106: 13469-13474
Basic Research: EP2 - receptor and agonist for treating glaucoma dysfunction (11-3, December 2009) on:
24080 Expression of prostaglandin PGE2 receptors under conditions of aging and stress and the protective effect of the EP2 agonist butaprost on retinal ischemia
Osborne NN; Li GY; Ji D et al.
Investigative Ophthalmology and Visual Science 2009; 50: 3238-3248
Comments (11-2, September 2009) on:
23848 Axonal regeneration induced by repetitive electrical stimulation of crushed optic nerve in adult rats
Tagami Y; Kurimoto T; Miyoshi T et al.
Japanese Journal of Ophthalmology 2009; 53: 257-266
Comments (11-1, June 2009) on:
22579 Effect of brimonidine on retinal ganglion cell survival in an optic nerve crush model
Ma K; Xu L; Zhang H et al.
American Journal of Ophthalmology 2009; 147: 326-331
Bloodflow: Vascular response in NTG (10-3, December 2008) on:
21712 Glaucoma is associated with peripheral vascular endothelial dysfunction
Su WW; Cheng ST; Ho WJ et al.
Ophthalmology 2008; 115: 1173-1178
Basic research: Neuroprotection and brimonidine (10-2, September 2008) on:
20899 Agreement between slit lamp examination and optical coherence tomography in estimating cup-disc ratios
Martinez-de-la-Casa JM; Saenz-Frances F; Fernandez-Vidal AM et al.
European Journal of Ophthalmology 2008; 18: 423-428
Basic research: Trabecular meshwork: FP receptor and IOP regulation (9-2, September 2007) on:
18231 Prostaglandin FP receptors do not contribute to 24-hour intraocular pressure variation in mice
Crowston JG; Morris CA; Lindsey JD et al.
Investigative Ophthalmology and Visual Science 2007; 48: 2095-2098
Medical treatment: Bunazocin (8-4, March 2007) on:
15116 Addition of or switch to topical bunazosin hydrochloride in elderly patients with normal-tension glaucoma: A one-year follow-up study
Yoshikawa K; Katsushima H; Kimura T et al.
Japanese Journal of Ophthalmology 2006; 50: 443-448
